Patient Problem Solving and Preventive Care

Patient Problem Solving and Preventive Care

Assistant Professor, faculty of Pharmacy, World University of Bangladesh

 International Journal of Hospital Pharmacy

Medications are powerful tools that, if used correctly, can prevent or treat disease. If used incorrectly, there is potential to cause great harm to people who take them. These unintended effects, called adverse effects, can occur from any medication. As health care teams, which include physicians, pharmacists, and other health care providers, are making decisions about using specific medications to treat an individual patient, they must weigh the potential risks against the desired benefit of each medication to minimize the chance of harm to the patient.
As important members of the health care team, pharmacists work collaboratively with patients’ other health care providers in all types of patient care settings ranging from community pharmacies to hospitals and long-term care facilities. Across these settings, pharmacists take specific actions that regularly contribute to improving patient safety. In addition to training on medications, pharmacist education and training includes assessing health status of patients, providing education and counseling, managing diseases, and using health care technologies. Pharmacists use this education and training to prevent medication errors, drug interactions, and other adverse medication events from reaching patients. With the expanding number and complexity of medications, pharmacists’ roles and responsibilities have expanded broadly beyond medication distribution. Pharmacists are providing patient care in almost all health care settings to help people of all ages get the most from the medications that are prescribed to them. Examples of pharmacists’ patient care services include providing health and wellness screenings, managing chronic diseases, assisting patients with medication management, administering immunizations, and working with hospitals and health systems to improve patient care and reduce the number of patients who are readmitted to the hospital following their hospital stay.

Keywords: Pharmacists; Healthcare; Prevention; Care; Risk; Drug; Patient

Free Full-text PDF

How to cite this article:
AK MOHIUDDIN, Patient Problem Solving and Preventive Care. International Journal of Hospital Pharmacy, 2019,4:20.


1. Office of Disease Prevention and Health Promotion (ODPHP). 2020 Topics and Objectives – Objectives A–Z. URL:
2. Vadher D, Cannon BC. Chapter 122. Development of a Pharmacy Care Plan and Patient Problem-Solving. In Joseph P Remington; Loyd V Allen, Jr. Remington: The Science And Practice Of Pharmacy 22nd Edition. Publisher: London; Philadelphia: Pharmaceutical Press, ©2013.
3. APhA. Principles of Practice for Pharmaceutical Care.
4. Zaal RJ, Jansen MM and others. Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts. Int J Clin Pharm. 2013 Oct;35(5):753-62. doi: 10.1007/s11096-013-9798-4. Epub 2013 May 29. PMID: 23715760
5. Shields KM, Blythe E. Chapter 3. Drug Information Resources. Drug Information: A Guide for Pharmacists, 4e. Copyright © 2012 by McGraw-Hill Education, LLC.
6. Smith M, Saunders R, Stuckhardt L. Chapter 7. Engaging Patients, Families, and Communities. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Committee on the Learning Health Care System in America; Institute of Medicine; Washington (DC): National Academies Press (US); 2013 May 10.
7. Ibrahim OHM, Ibrahim RM. Community pharmacists’ involvement in breast cancer health promotion in United Arab Emirates (UAE). Am J Pharmacol Toxicol 2013;8(4):155-63.
8. Odedin FT, Warrick C, Vilme H, Young S. Pharmacists as health educators and risk communicators in the early detection of prostate cancer. Res Soc Admin Pharm 2008;4(1): 59-66.
9. Jordan MA and Harmon J. Pharmacist interventions for obesity: improving treatment adherence and patient outcomes. Integr Pharm Res Pract. 2015; 4: 79–89. doi: [10.2147/IPRP.S72206] PMID: 29354522
10. Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2015. Toronto (ON): Canadian Cancer Society; 2015.
11. Lum BL, McWaters DS, Mergener MA. Cancer detection and the community pharmacist. Am Pharm. 1989 Jul; NS29(7):54-9.
12. Richards MA. The size of the prize for earlier diagnosis of cancer in England. Br J Cancer. 2009 Dec 3; 101 Suppl 2:S125-9.
13. Havlicek AJ, Mansell H. The community pharmacist’s role in cancer screening and prevention. Can Pharm J (Ott). 2016 Sep; 149(5): 274–282. doi: [10.1177/1715163516660574] PMID: 27708673
14. Seely JM, Alhassan M. Screening for breast cancer in 2018—what should we be doing today? Curr Oncol. 2018 Jun; 25(Suppl 1): S115–S124. doi: [10.3747/co.25.3770] PMID: 29910654
15. Calis KA, Hutchison LC, Elliott ME, Ives TJ, Zillich AJ, Poirier T, Raebel MA. Healthy people 2010: challenges, opportunities, and a call to action for America’s pharmacists. Pharmacotherapy. 2004;24(9):1241–1294. doi: 10.1592/phco.24.13.1241.38082.
16. Naz MSG, Kariman N and others. Educational Interventions for Cervical Cancer Screening Behavior of Women: A Systematic Review. Asian Pac J Cancer Prev. 2018; 19(4): 875–884. doi: [10.22034/APJCP.2018.19.4.875] PMID: 29693331
17. Lambert P, Bingley PJ. What is Type 1 Diabetes? Medicine 2002;30(1):1‒5 URL:
18. Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother. 1996 Mar; 30(3):238-43.
19. WHO web. Cardiovascular disease. World Heart Day. Scale up prevention of heart attack and stroke. URL:
20. WHO web. News/ Fact sheets/Detail/Cardiovascular diseases (CVDs). 17 May 2017
21. Swieczkowski D, Merks P, Gruchala M, et al. The role of the pharmacist in the care of patients with cardiovascular diseases. Kardiol Pol 2016;74:1319–26
22. Harper-Harrison G, Shanahan MM. Hormone Replacement Therapy. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
23. Felty Q. Estrogen-induced DNA synthesis in vascular endothelial cells is mediated by ROS signaling. BMC Cardiovasc. Disord. 2006;6:16 doi: 10.1186/1471-2261-6-16
24. Chen S.J., Li H., Durand J., Oparil S., Chen Y.F. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation. 1996;93:577–584. doi: 10.1161/01.CIR.93.3.577.
25. Wilson P.W., Kannel W.B., Silbershatz H., D’Agostino R.B. Clustering of metabolic factors and coronary heart disease. Arch. Intern. Med. 1999;159:1104–1109. doi: 10.1001/archinte.159.10.1104
26. Ho-Pham L.T., Nguyen N.D., Vu B.Q., Pham H.N., Nguyen T.V. Prevalence and risk factors of radiographic vertebral fracture in postmenopausal Vietnamese women. Bone. 2009;45:213–217. doi: 10.1016/j.bone.2009.04.199
27. PriorityHealth. CMS/Medicare high-risk medication list. Accessed May 10, 2015.
28. Tu KN, Lie JD, Wan CKV, et al. Osteoporosis: A Review of Treatment Options. P T. 2018;43(2):92-104.
29. Hall SF, Edmonds SW, Lou Y, et al. Patient-reported reasons for nonadherence to recommended osteoporosis pharmacotherapy. J Am Pharm Assoc (2003). 2017;57(4):503-509.
30. Jaleel A, Saag KG, Danila MI. Improving drug adherence in osteoporosis: an update on more recent studies. Ther Adv Musculoskelet Dis. 2018;10(7):141-149.
31. Martin L, Oepen R, Bauer K, et al. Creative Arts Interventions for Stress Management and Prevention-A Systematic Review. Behav Sci (Basel). 2018;8(2):28. Published 2018 Feb 22. doi:10.3390/bs8020028
32. Wedgwood J. Cut costs by focusing on absenteeism this financial year. The Happiness Index (HPI) March, 2018.
33. Cook D. Workplace stress costing employers $500 billion annually. Benefitspro.Com October 20, 2017.
34. Kessler RC, Bromet EJ. The Epidemiology of Depression Across Cultures. Annu. Rev. Public Health 2013. 34:119–38
35. Molenaar NM, Kamperman AM, Boyce P, Bergink V. Guidelines on treatment of perinatal depression with antidepressants: An international review. Aust N Z J Psychiatry. 2018;52(4):320-327.
36. Chesney, Goodwin and Fazel (2014). Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry, 13: 153-60.
37. Chen W, Wang S, Wang Q, et al. Direct medical costs of hospitalizations for mental disorders in Shanghai, China: a time series study. BMJ Open 2017; 7: e015652. doi:10.1136/ bmjopen-2016-015652
38. Harms M, Haas M, Larew J, DeJongh B. Impact of a mental health clinical pharmacist on a primary care mental health integration team. Ment Health Clin. 2018;7(3):101-105. Published 2018 Mar 23. doi:10.9740/mhc.2017.05.101
39. Shapiro NL. Chapter 126. Preventive Care. In Joseph P Remington; Loyd V Allen, Jr. Remington: The Science And Practice Of Pharmacy 22nd Edition. Publisher: London; Philadelphia: Pharmaceutical Press, ©2013.
40. Loew N, Lehan Mackin M, Ayres L. Concept Analysis of Responsible Sexual Behavior in Adult Women. J Obstet Gynecol Neonatal Nurs. 2018 May;47(3):385-395. doi: 10.1016/j.jogn.2018.01.006. Epub 2018 Feb 15. PubMed PMID: 29453953.
41. Miranda PSF, Aquino JMG, Monteiro RMPC, Dixe MDACR, Luz AMBD, Moleiro P. Sexual behaviors: study in the youth. Einstein (Sao Paulo). 2018;16(3):eAO4265. Published 2018 Sep 17. doi:10.1590/S1679-45082018AO4265
42. Derbyshire KL, Grant JE. Compulsive sexual behavior: a review of the literature. J Behav Addict. 2015;4(2):37-43.
43. Wood H, Gudka S. Pharmacist-led screening in sexually transmitted infections: current perspectives. Integr Pharm Res Pract. 2018;7:67-82. Published 2018 Jun 15. doi:10.2147/IPRP.S140426
44. Deppe SJ, Nyberg CR, Patterson BY, Dietz CA, Sawkin MT. Expanding the role of a pharmacist as a sexually transmitted infection provider in the setting of an urban free health clinic. Sex Transm Dis. 2013 Sep;40(9):685-8. doi: 10.1097/OLQ.0000000000000010. PubMed PMID: 23945423.
45. Bock BC, Hudmon KS, Christian J, Graham AL, Bock FR. A tailored intervention to support pharmacy-based counseling for smoking cessation. Nicotine Tob Res. 2010;12(3):217-25.
46. Sanii Y, Torkamandi H, Gholami K, Hadavand N, Javadi M. Role of pharmacist counseling in pharmacotherapy quality improvement. J Res Pharm Pract. 2016;5(2):132-7.

Terms of Use/Privacy Policy/ Disclaimer/ Other Policies:
You agree that by using our site, you have read, understood, and agreed to be bound by all of our terms of use/privacy policy/ disclaimer/ other policies (click here for details).

This work and its PDF file(s) are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.